Published in Int J Health Serv on January 01, 1980
Promoting rational prescribing: an international perspective. Br J Clin Pharmacol (1995) 2.88
Cost-effectiveness appraisal of immunization programmes. Bull World Health Organ (1982) 1.74
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab (1997) 5.84
The quality of diabetic care in a London health district. J Epidemiol Community Health (1980) 3.78
Developing a district diabetic register. BMJ (1992) 2.92
Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia (2010) 2.71
Thrombolysis in patients with diabetes. BMJ (1995) 2.61
Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab (2002) 2.30
Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta (1997) 2.01
Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) (1986) 1.87
The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia (1990) 1.72
Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India (2006) 1.69
Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol (1999) 1.62
The glycohaemoglobin assay as a screening test for diabetes mellitus: the Islington Diabetes Survey. Diabet Med (1987) 1.61
Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care (1997) 1.58
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57
Adiposity, inflammation and hyperglycaemia in rural and urban Indian men: Coronary Risk of Insulin Sensitivity in Indian Subjects (CRISIS) Study. Diabetologia (2007) 1.51
Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ (1993) 1.45
Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes (1997) 1.44
Insulin resistance, insulin, proinsulin, and ambulatory blood pressure in type II diabetes. Hypertension (1994) 1.37
Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet (1984) 1.36
Non-mydriatic retinal photography as a screening service for general practitioners. Diabet Med (1990) 1.30
Glucose intolerance and hypertension in north London: the Islington Diabetes Survey. Diabet Med (1987) 1.26
Hypertension and non-insulin dependent diabetes. BMJ (1991) 1.25
The insulin dilemma in resource-limited countries. A way forward? Diabetologia (2010) 1.21
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. Diabetes Care (1993) 1.17
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis (2005) 1.17
Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test. Br J Ophthalmol (1986) 1.17
Fetal programming and the Leningrad Siege study. Twin Res (2001) 1.15
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord (2002) 1.13
How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria. Nephrol Dial Transplant (1998) 1.11
Body fat measurement in Indian men: comparison of three methods based on a two-compartment model. Int J Obes (Lond) (2005) 1.09
Reversible coma in Wernicke's encephalopathy. Postgrad Med J (1985) 1.08
Genetic vs environmental factors in insulin-dependent diabetes mellitus. Lancet (1997) 1.08
Screening for diabetic retinopathy--comparison of a nurse and a doctor with retinal photography. Diabetes Res (1987) 1.07
Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res (2003) 1.06
A second open letter to the General Medical Council. Med Educ (1986) 1.06
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol (2007) 1.02
Effect of vitamin C on glycosylation of proteins. Diabetes (1992) 1.02
A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. Diabetes Res Clin Pract (1992) 1.01
Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant (2001) 1.01
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost (2003) 1.00
Access to medical information in developing countries. Lancet (2000) 0.99
The abbreviated glucose tolerance test in screening for diabetes: the Islington Diabetes Survey. Diabet Med (1988) 0.99
Effects of fish oil supplements in NIDDM subjects. Controlled study. Diabetes Care (1990) 0.99
Diabetes mellitus and early mortality from stroke. Br Med J (Clin Res Ed) (1985) 0.98
Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) (2002) 0.97
Medical ethics and the clinical curriculum: a case study. J Med Ethics (1987) 0.97
Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations. Eur J Clin Nutr (2013) 0.97
Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract (1988) 0.97
Fatal rhabdomyolysis associated with hyperosmolar diabetic decompensation. Diabetes Res (1988) 0.95
High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease. Diabetes Care (1999) 0.94
Peyronie's disease in association with metoprolol. Lancet (1978) 0.94
Sodium and blood pressure: positive associations in a north London population with consideration of the methodological problems of within-population surveys. J Hum Hypertens (1988) 0.93
Four assay methods for glycated hemoglobin compared as screening tests for diabetes mellitus: the Islington Diabetes Survey. Clin Chem (1988) 0.93
Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes (1995) 0.92
Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab (1998) 0.92
Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin Endocrinol (Oxf) (1999) 0.91
Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med (1987) 0.90
Which diabetic patients should be taking aspirin? BMJ (1995) 0.89
Brittle diabetes in the elderly. Diabet Med (1989) 0.88
Platelet catecholamine concentrations after short-term stress in normal subjects. Clin Sci (Lond) (1994) 0.87
The pattern of diabetic complications in African patients in Dar es Salaam. Trop Geogr Med (1980) 0.86
Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabet Med (1993) 0.86
Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J (1988) 0.86
Hyperglycaemia, diabetes and myocardial infarction. Diabet Med (1987) 0.84
An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol (Oxf) (1999) 0.84
Central obesity, depression and the hypothalamo-pituitary-adrenal axis in men and postmenopausal women. Int J Obes Relat Metab Disord (2000) 0.84
The Diabetes UK Mozambique Twinning Programme. Results of improvements in diabetes care in Mozambique: a reassessment 6 years later using the Rapid Assessment Protocol for Insulin Access. Diabet Med (2010) 0.84
Anticardiolipin antibody levels in diabetic subjects with and without coronary artery disease. Postgrad Med J (1989) 0.84
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis (2004) 0.84
Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism (1998) 0.84
Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients. Br Heart J (1993) 0.83
Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects--evidence against a modulating role for insulin. Diabetologia (1995) 0.83
Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol (Oxf) (1990) 0.82
Evidence of impaired glomerular charge selectivity in nondiabetic subjects with microalbuminuria: relevance to cardiovascular disease. Arterioscler Thromb Vasc Biol (1996) 0.82
Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus. Diabet Med (1996) 0.81
The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study. Diabet Med (1998) 0.81
Diabetes, impaired glucose tolerance and cardiovascular disease risk factors in the Asian Indian Bhatia community living in Tanzania and in the United Kingdom. Diabet Med (1995) 0.81
Exercise-induced changes in platelet aggregation; a comparison of whole blood and platelet rich plasma techniques. Thromb Res (1988) 0.81
A comparison of premixed with patient-mixed insulins. Diabet Med (1986) 0.80
The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation (1995) 0.80
Increased response of cortisol and ACTH to corticotrophin releasing hormone in centrally obese men, but not in post-menopausal women. Int J Obes Relat Metab Disord (2000) 0.80
A within patient cross over trial of 4 insulin regimens in antibody-negative, C-peptide negative patients. Diabetes Res (1987) 0.80
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome. Diabetologia (1996) 0.80
Provision of medicines in a developing country. Lancet (1978) 0.80
Compiling a district diabetic register: theoretical and practical considerations. Diabet Med (1993) 0.80
Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes. Diabetes Care (1998) 0.80
An algorithm for tight glycaemic control in diabetic infarct survivors. Diabetes Res Clin Pract (1992) 0.80
Withdrawal of clonidine. Lancet (1977) 0.80
Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction. Arterioscler Thromb (1993) 0.80
Treating hypertension in non-insulin-dependent diabetes: a comparison of atenolol, nifedipine, and captopril combined with bendrofluazide. Diabet Med (1987) 0.79
Deoxyribonucleic acid polymorphism of the apoprotein AI-CIII-AIV gene cluster and coronary heart disease in non-insulin-dependent diabetes. Br Med J (Clin Res Ed) (1987) 0.79
Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? Br Heart J (1993) 0.79
Measurement of fingertip blood flow using thermal clearance reflects anastomotic rather than nutrient blood flow. Clin Sci (Lond) (1987) 0.79
Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjects. J Diabetes Complications (1994) 0.79
Urine analysis for glucose and protein. BMJ (1990) 0.79